Upsendy
10-10-2022, 06:14 PM
In clinical trials with tamoxifen of 1 year or less, 2 years, and about 5 years duration, the proportional reductions in the incidence rate of contralateral breast cancer among women receiving tamoxifen were 13 not significant, 26 2p 0 metolazone and lasix ([Only registered and activated users can see links]) There is plenty of data to support its effectiveness